| Filed On | Filing |
|---|---|
| 29 Dec 2021 |
Form 4: Koppel Adam, Director
Disposed of 3,083,570 shares (Tender Offer) ($118M) · Disposed of 3,333 Restricted Stock Units (Disposition to Issuer) · Disposed of 130,000 Director Stock Option (Right to Buy) (Disposition to Issuer) |
| 29 Dec 2021 |
Form 4: Zeng Ling, Chief Legal Officer & Sec'y
Disposed of 5,032 shares (Tender Offer) ($192K) · Disposed of 21,357 Restricted Stock Units (Disposition to Issuer) · Disposed of 127,945 Employee Stock Option (Right to Buy) (Disposition to Issuer) |
| 29 Dec 2021 |
Form 4: Weissman James B, Chief Operating Officer & EVP
Disposed of 18,100 shares (Tender Offer) ($692K) · Disposed of 37,275 Restricted Stock Units (Disposition to Issuer) · Disposed of 707,078 Employee Stock Option (Right to Buy) (Disposition to Issuer) |
| 29 Dec 2021 |
Form 4: Smith Cynthia, Director
Disposed of 3,333 shares (Tender Offer) ($127K) · Disposed of 3,333 Restricted Stock Units (Disposition to Issuer) · Disposed of 80,000 Director Stock Option (Right to Buy) (Disposition to Issuer) |
| 29 Dec 2021 |
Form 4: Pagan Douglas W., Chief Financial Officer
Disposed of 7,775 shares (Tender Offer) ($297K) · Disposed of 26,625 Restricted Stock Units (Disposition to Issuer) · Disposed of 132,550 Employee Stock Option (Right to Buy) (Disposition to Issuer) |
| 29 Dec 2021 |
Form 4: Kozin Marc D, Director
Returned 11,333 shares to the issuer ($433K) · Disposed of 3,333 Restricted Stock Units (Disposition to Issuer) · Disposed of 80,000 Director Stock Option (Right to Buy) (Disposition to Issuer) |
| 29 Dec 2021 |
Form 4: Hoffman Stephen J, Director
Disposed of 16,157 shares (Tender Offer) ($618K) · Disposed of 3,333 Restricted Stock Units (Disposition to Issuer) · Disposed of 175,000 Director Stock Option (Right to Buy) (Disposition to Issuer) |
| 29 Dec 2021 |
Form 4: Gray Patrick M., Director
Disposed of 3,333 shares (Tender Offer) ($127K) · Disposed of 3,333 Restricted Stock Units (Disposition to Issuer) · Disposed of 55,000 Director Stock Option (Right to Buy) (Disposition to Issuer) |
| 29 Dec 2021 |
Form 4: Freed Martin I, Director
Disposed of 3,333 shares (Tender Offer) ($127K) · Disposed of 3,333 Restricted Stock Units (Disposition to Issuer) · Disposed of 130,000 Director Stock Option (Right to Buy) (Disposition to Issuer) |
| 29 Dec 2021 |
Form 4: Fambrough Douglas, Director
Returned 231,431 shares to the issuer ($8.85M) · Disposed of 101,100 Restricted Stock Units (Disposition to Issuer) · Disposed of 2,707,235 Employee Stock Option (Right to Buy) (Disposition to Issuer) |
| 29 Dec 2021 |
Form 4: Doberstein Stephen K, Director
Disposed of 3,333 shares (Tender Offer) ($127K) · Disposed of 3,333 Restricted Stock Units (Disposition to Issuer) · Disposed of 55,000 Director Stock Option (Right to Buy) (Disposition to Issuer) |
| 29 Dec 2021 |
Form 4: Ciappenelli Robert D., Chief Strategy Officer
Disposed of 14,813 shares (Tender Offer) ($567K) · Disposed of 27,600 Restricted Stock Units (Disposition to Issuer) · Disposed of 407,644 Employee Stock Option (Right to Buy) (Disposition to Issuer) |
| 29 Dec 2021 |
Form 4: Buchi J Kevin, Director
Disposed of 4,666 shares (Tender Offer) ($178K) · Disposed of 3,333 Restricted Stock Units (Disposition to Issuer) · Disposed of 102,000 Director Stock Option (Right to Buy) (Disposition to Issuer) |
| 29 Dec 2021 |
Form 4: Brown Bob D, Chief Scientific Ofr., EVP R&D
Disposed of 2,367 shares (Tender Offer) ($90.5K) · Disposed of 37,275 Restricted Stock Units (Disposition to Issuer) · Disposed of 799,450 Employee Stock Option (Right to Buy) (Disposition to Issuer) |
| 29 Dec 2021 |
Form 4: Aradhye Shreeram, EVP & Chief Medical Officer
Disposed of 6,973 shares (Tender Offer) ($267K) · Disposed of 29,588 Restricted Stock Units (Disposition to Issuer) · Disposed of 175,770 Employee Stock Option (Right to Buy) (Disposition to Issuer) |
| 17 Dec 2021 |
Form 4: Pagan Douglas W., Chief Financial Officer
Received 2,050 shares by exercise or conversion · Gave up 602 shares to cover exercise price or tax ($22.9K) |
| 17 Dec 2021 |
Form 4: Ciappenelli Robert D., Chief Strategy Officer
Received 3,425 shares by exercise or conversion · Gave up 1,241 shares to cover exercise price or tax ($47.2K) |
| 17 Dec 2021 |
Form 4: Aradhye Shreeram, EVP & Chief Medical Officer
Received 2,837 shares by exercise or conversion · Gave up 833 shares to cover exercise price or tax ($31.7K) |
| 17 Dec 2021 |
Form 4: Weissman James B, Chief Operating Officer & EVP
Received 3,775 shares by exercise or conversion · Gave up 1,675 shares to cover exercise price or tax ($63.7K) |
| 17 Dec 2021 |
Form 4: Fambrough Douglas, Director
Received 13,750 shares by exercise or conversion · Gave up 5,348 shares to cover exercise price or tax ($203K) |
Loading...